Results 111 to 120 of about 468,328 (281)

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Impact of Auxiliary Information and Measurement Errors on Mean Estimation with Mixture Optional Enhanced Trust (MOET) Randomized Response Model

Axioms
Randomized response technique (RRT) surveys are designed to secure honest answers to sensitive questions. In this study, we consider the important issue of measurement error (ME).
Michael Parker, Sat Gupta, Sadia Khalil
doaj   +1 more source

Estimation of finite population mean for a sensitive variable using dual auxiliary information in the presence of measurement errors.

PLoS ONE, 2019
In this study, we propose a new improved estimator of population mean for the sensitive variable in the presence of measurement error under simple and stratified random sampling.
Erum Zahid, Javid Shabbir
doaj   +1 more source

A new improved generalized class of estimators for population distribution function using auxiliary variable under simple random sampling. [PDF]

Sci Rep, 2023
Ahmad S, Ullah K, Zahid E, Shabbir J, Aamir M, Alshanbari HM, El-Bagoury AAH.   +6 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

A simulation study: Improved ratio-in-regression type variance estimator based on dual use of auxiliary variable under simple random sampling. [PDF]

PLoS One, 2022
Ahmad S, Hussain S, Ullah K, Zahid E, Aamir M, Shabbir J, Ahmad Z, Alshanbari HM, Alajlan W.   +8 more
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Improving RBS estimates - effects of the auxiliary variable, stratification of the crown, and deletion of segments on the precision of estimates

Journal of Forest Science, 2007
Randomized Branch Sampling (RBS) is a multistage sampling procedure using natural branching in order to select samples for the estimation of tree characteristics.
J. Cancino, J. Saborowski
doaj   +1 more source

Bayesian auxiliary variable model for birth records data with qualitative and quantitative responses. [PDF]

J Stat Comput Simul, 2021
Kang X, Ranganathan S, Kang L, Gohlke J, Deng X.   +4 more
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source